Idera Pharmaceuticals Inc expected to post a loss of 11  cents a share - Earnings Preview

Aceragen

25/02/2022 12:03

* Idera Pharmaceuticals Inc  IDRA.OQ   IDRA.O  is expected
to show
no change in quarterly revenue when it reports  results on
February 28 (estimated). 
    * ​Refinitiv's mean analyst estimate for Idera
Pharmaceuticals Inc
is for a loss of 11 cents per share. For the same quarter last
year, the company reported a loss of $2.11 per share.
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated February 25 at 12:03 GMT. 
All figures in US dollars  unless otherwise stated